Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 27, 2015 1:42 PM ET

Healthcare Equipment and Supplies

Company Overview of AxoGen, Inc.

Company Overview

AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company’s surgical nerve repair solutions include Avance Nerve Graft, a proprietary processed nerve allograft for bridging severed nerves without the comorbidities associated with a nerve autograft surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. It also offe...

13631 Progress Boulevard

Suite 400

Alachua, FL 32615

United States

84 Employees





Key Executives for AxoGen, Inc.

Chief Executive Officer, President and Director
Age: 52
Total Annual Compensation: $314.5K
Senior Vice President of Business Development, General Counsel and Director
Age: 52
Total Annual Compensation: $251.6K
Senior Vice President of Sales
Age: 56
Total Annual Compensation: $314.6K
Chief Marketing Officer
Age: 48
Total Annual Compensation: $231.1K
Compensation as of Fiscal Year 2013.

AxoGen, Inc. Key Developments

AxoGen, Inc. Presents at Canaccord Genuity 10th Annual Musculoskeletal Conference, Mar-24-2015 04:30 PM

AxoGen, Inc. Presents at Canaccord Genuity 10th Annual Musculoskeletal Conference, Mar-24-2015 04:30 PM. Venue: MGM Grand Hotel, Las Vegas, Nevada, United States.

AxoGen, Inc. Announces Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Revenue Guidance for 2015

AxoGen, Inc. announced consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, revenues totaled $4.79 million, a 61% increase compared to $2.98 million in the prior year fourth quarter. Net loss was $6.5 million or $0.35 per share compared to net loss of $4.1 million or $0.24 per share for the fourth quarter of 2013. For the year, revenues were $16,817,403 against $10,947,361 a year ago. Loss from operations was $9,800,790 against $9,592,205 a year ago. Net Loss available to common shareholders was $17,710,476 against $14,556,885 a year ago. Basic and diluted loss per share was $0.99 against $1.08 a year ago. Net cash used for operating activities was $10,451,059 against $10,444,758 a year ago. Purchase of property and equipment was $542,045 against $178,776 a year ago. Acquisition of intangible assets was $52,002 against $65,189 a year ago. Based on the market's increasing awareness of the company's product portfolio, continued expansion of its sales footprint and current sales pipeline, the company currently anticipates 2015 full year revenue to exceed $24 million and annual gross margin in the mid to high 70% range.

AxoGen, Inc. to Report Q4, 2014 Results on Mar 05, 2015

AxoGen, Inc. announced that they will report Q4, 2014 results After-Market on Mar 05, 2015

Similar Private Companies By Industry

Company Name Region
VTS Medical Systems, Inc. United States
Wyant Corporation United States
Cerebrotech Medical Systems, Inc. United States
VisionCare Ophthalmic Technologies, Inc. United States
BFKW, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AxoGen, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at